Topotecan in the treatment of acquired immunodeficiency syndrome-related progressive multifocal leukoencephalopathy (original) (raw)

• Barnett AA (1996). FDA approve bark-derived drug. Lancet 347: 1613.
  PubMed CAS Google Scholar
• Berger JR (2000). Progressive multifocal leukoencephalopathy. Curr Treat Options Neurol 2: 361–368.
  Article PubMed Google Scholar
• Berger JR, Kaszovitz B, et al (1987). Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of sixteen cases. Ann Intern Med 107: 78–87.
  PubMed CAS Google Scholar
• Berger JR, Major EO (1999). Progressive multifocal leukoencephalopathy. Semin Neurol 19: 193–200.
  Article PubMed CAS Google Scholar
• Brambilla AM, Castagna A, et al (1999). Remission of AIDS-associated progressive multifocal leukoencephalopathy after cidofovir therapy. J Neurol 246: 723–725.
  Article PubMed CAS Google Scholar
• Brown P, Tsai T, et al (1975). Seroepidemiology of human papovaviruses. Discovery of virgin populations and some unusual patterns of antibody prevalence among remote peoples of the world. Am J Epidemiol 102: 331–340.
  PubMed CAS Google Scholar
• Chang L, Ernst T, et al (1997). Metabolite abnormalities in progressive multifocal leukoencephalopathy by proton magnetic resonance spectroscopy. Neurology 48: 836–845.
  PubMed CAS Google Scholar
• Clifford DB, Yiannoutsos C, et al (1999). HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology 52: 623–625.
  PubMed CAS Google Scholar
• De Luca A, Giancola ML, et al (2000). Cidofovir added to HAART improves virological and clinical outcome in AIDS-associated progressive multifocal leukoencephalopathy. AIDS 14: F117-F121.
  Article PubMed Google Scholar
• Dore GJ, Correll PK, et al (1999). Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 13: 1249–1253.
  Article PubMed CAS Google Scholar
• Dworkin MS, Wan PC, et al (1999). Progressive multifocal leukoencephalopathy: improved survival of human immunodeficiency virus-infected patients in the protease inhibitor era. J Infect Dis 180: 621–625.
  Article PubMed CAS Google Scholar
• Enting RH, Portegies P (2000). Cytarabine and highly active antiretroviral therapy in HIV-related progressive multifocal leukoencephalopathy. J Neurol 247: 134–138.
  Article PubMed CAS Google Scholar
• Ernst T, Chang L, et al (1999). Progressive multifocal leukoencephalopathy and human immunodeficiency virus-associated white matter lesions in AIDS: magnetization transfer MR imaging. Radiology 210: 539–543.
  PubMed CAS Google Scholar
• Evans RH, Scadden DT (2000). Haematological aspects of HIV infection. Baillieres Best Pract Res Clin Haematol 13: 215–230.
  Article PubMed CAS Google Scholar
• Fong IW, Toma E (1995). The natural history of progressive multifocal leukoencephalopathy in patients with AIDS. Canadian PML Study Group. Clin Infect Dis 20: 1305–1310.
  PubMed CAS Google Scholar
• Gasnault J, Kousignian P, et al (2001). Cidofovir in AIDS-associated progressive multifocal leukoencephalopathy: a monocenter observational study with clinical and JC virus load monitoring. J Neurovirol 7: 375–381.
  Article PubMed CAS Google Scholar
• Gasnault J, Taoufik Y, et al (1999). Prolonged survival without neurological improvement in patients with AIDS-related progressive multifocal leukoencephalopathy on potent combined antiretroviral therapy. J Neurovirol 5: 421–429.
  Article PubMed CAS Google Scholar
• Geschwind MD, Skolasky RI, et al (2001). The relative contributions of HAART and alpha-interferon for therapy of progressive multifocal leukoencephalopathy in AIDS. J NeuroVirol 7: 353–357.
  Article PubMed CAS Google Scholar
• Hochster H, Liebes L, et al (1994). Phase I trial of low-dose continuous topotecan infusion in patients with cancer: an active and well-tolerated regimen. J Clin Oncol 12: 553–559.
  PubMed CAS Google Scholar
• Huang SS, Skolasky RL, et al (1998). Survival prolongation in HIV-associated progressive multifocal leukoencephalopathy treated with alpha-interferon: an observational study. J Neurovirol 4: 324–332.
  Article PubMed CAS Google Scholar
• Itti L, Chang L, et al (2001). Segmentation of progressive multifocal leukoencephalopathy lesions in fluid-attenuated inversion recovery magnetic resonance imaging. J Neuroimaging 11: 412–417.
  Article PubMed CAS Google Scholar
• Kerr DA, Chang CF, et al (1993). Inhibition of human neurotropic virus (JCV) DNA replication in glial cells by camptothecin. Virology 196: 612–618.
  Article PubMed CAS Google Scholar
• Li CJ, Zhang LJ, et al (1993). Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication. Proc Natl Acad Sci USA 90: 1839–1842.
  Article PubMed CAS Google Scholar
• Major EO, Amemiya K, et al (1992). Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev 5: 49–73.
  PubMed CAS Google Scholar
• Moore RD, Chaisson RE (1999). Natural history of HIV infection in the era of combination antiretroviral therapy. AIDS 13: 1933–1942.
  Article PubMed CAS Google Scholar
• Nicoli F, Chave B, et al (1992). Efficacy of cytarabine in progressive multifocal leucoencephalopathy in AIDS. Lancet 339: 306.
  Article PubMed CAS Google Scholar
• Portegies P, Algra PR, et al (1991). Response to cytarabine in progressive multifocal leucoencephalopathy in AIDS. Lancet 337: 680–681.
  Article PubMed CAS Google Scholar
• Sacktor N, Lyles RH, et al (2001). HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990–1998. Neurology 56: 257–260.
  PubMed CAS Google Scholar
• Sausville EA, Horwitz SB (1978). Inhibition of SV40 DNA synthesis by camptothecin and neocarzinostatin. Mol Pharmacol 14: 1156–1166.
  PubMed CAS Google Scholar
• Tantisiriwat W, Tebas P, et al (1999). Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapy. Clin Infect Dis 28: 1152–1154.
  Article PubMed CAS Google Scholar
• Taoufik Y, Delfraissy JF, et al (2000). Highly active antiretroviral therapy does not improve survival of patients with high JC virus load in the cerebrospinal fluid at progressive multifocal leukoencephalopathy diagnosis. AIDS 14: 758–759.
  Article PubMed CAS Google Scholar
• Weiner SM, Laubenberger J, et al (2000). Fatal course of HIV-associated progressive multifocal leukoencephalopathy despite successful highly active antiretroviral therapy. J Infect 40: 100–102.
  Article PubMed CAS Google Scholar
• Yang L, Wold MS, et al (1987). Roles of DNA topoisomerases in simian virus 40 DNA replication in vitro. Proc Natl Acad Sci USA 84: 950–954.
  Article PubMed CAS Google Scholar
• Yiannoutsos CT, De Luca A (2001). Designs for clinical trials to test the efficacy of therapeutics in progressive multifocal leukoencephalopathy. J NeuroVirol 7: 369–374.
  Article PubMed CAS Google Scholar
• Zhang JL, Sharma PL, et al (1997). Topotecan inhibits human immunodeficiency virus type 1 infection through a topoisomerase-independent mechanism in a cell line with altered topoisomerase I. Antimicrob Agents Chemother 41: 977–981.
  PubMed CAS Google Scholar